ONCTERNAL THERAPEUTICS INC - COM (ONCT)

CUSIP: 68236P107

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM
Total 13F shares
1,259,576
Share change
+132,301
Total reported value
$4,976,016
Price per share
$3.95
Number of holders
20
Value change
+$506,395
Number of buys
6
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 68236P107?
CUSIP 68236P107 identifies ONCT - ONCTERNAL THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCTERNAL THERAPEUTICS INC - COM (ONCT) as of Q4 2019

As of 31 Dec 2019, ONCTERNAL THERAPEUTICS INC - COM (ONCT) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,259,576 shares. The largest 10 holders included Creative Planning, VANGUARD GROUP INC, DOWLING & YAHNKE LLC, UNITED CAPITAL FINANCIAL ADVISERS, LLC, Aureus Asset Management, LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 20 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.